This new research follows other recent Company developments relating to the use of accelerated protocols with its products.

Carrum Health launched a substance use disorder treatment program for employers a year ago and has now expanded it to include ...

Sinclair Method uses naltrexone, a medication that is often used for the treatment of opioid use disorder, to reduce the ...

GLP-1s hold promise as a potential treatment for alcohol and substance use disorders, according to an expert endocrine ...

Getty Images The limited treatment options available for alcohol use disorder emphasize the urgent need for more research into pharmacological therapies. While more research is needed, preclinical and ...

Carrum Health, the leader in value-based Centers of Excellence (COE) for specialty care, today announced it has expanded the ...

Pemvidutide is a novel, peptide-based GLP-1/glucagon dual receptor agonist. The Food and Drug Administration (FDA) has granted Fast Track designation to pemvidutide for the treatment of alcohol use ...

Please provide your email address to receive an email when new articles are posted on . Pharmacotherapy appears to be underused in alcohol use disorder, especially among those with related liver ...

Milestone advances MEAI-based therapy targeting a global Alcohol Use Disorder treatment market projected to surpass $20 billion by 2032Vancouver, ...

Baclofen, a GABA B receptor agonist traditionally used as a muscle relaxant, has emerged as a promising pharmacological option in the management of Alcohol Use Disorder (AUD). By modulating inhibitory ...

Find effective treatment options, support strategies and what to expect during recovery from alcohol use disorder to achieve ...

The latest issues of three American Psychiatric Association journals (The American Journal of Psychiatry, Psychiatric Services and Focus) are now available online.